GenesisX Robotic Magnetic Navigation System

GenesisX addresses the primary adoption barrier that limited earlier robotic magnetic navigation systems—the requirement for expensive, time-consuming room construction. By integrating magnetic shielding directly into the system structure, GenesisX enables installation in existing cardiac catheterization labs over a single weekend.

Product Overview

GenesisX combines the established clinical benefits of robotic magnetic navigation with dramatically enhanced accessibility. The system’s compact, semi-mobile design eliminates infrastructure requirements that historically prevented community hospitals from adopting RMN technology.

When parked, the magnetic fields are contained within the system base, allowing the room to function without restriction for non-robotic procedures. This dual-use capability maximizes lab utilization while providing access to robotic precision when needed.

Key Features

Designed to fit in existing cardiac catheterization labs, GenesisX integrates magnetic shielding into its base, enabling weekend installation without room modification or structural anchoring.

• Integrated Magnetic Shielding: No room modification required; shielding built into system structure
• Weekend Installation: Can be set up in existing cath labs without construction downtime
• Standard Power: Operates on 120/230V facility power without special electrical requirements
• No Structural Anchoring: Freestanding design requires no floor modifications
• 80% Smaller Cabinet: Fits conveniently under operating room tables
• Dual-Use Room: Lab functions normally for manual procedures when robot is parked

Technical Specifications

GenesisX fits under operating room tables with an 80%-smaller cabinet, runs on standard 120/230 V power, and installs in 2–3 days at 1 mm/1° navigation precision with no structural changes.

Clinical Applications

GenesisX supports the same range of cardiac ablation procedures as Genesis:

Atrial Fibrillation: Precise pulmonary vein isolation and substrate modification for persistent AF.

Ventricular Tachycardia: Access to scarred myocardium for substrate-based VT ablation.

Supraventricular Tachycardia: High success rates for accessory pathway and nodal reentrant arrhythmias.

The clinical capabilities remain identical to Genesis while dramatically expanding which facilities can offer robotic EP services.

Regulatory Status

Stereotaxis initiated limited commercial launch in the US and Europe following regulatory approvals, with full commercial launch planned for 2026.

Market Impact

GenesisX represents Stereotaxis’ strategy to transition from a niche technology requiring major capital investment to a broadly accessible surgical robot. Key advantages for hospital administrators:

• Reduced Capital Cost: Eliminates room construction expense
• Faster Time to Revenue: Weekend installation versus months of construction
• Flexible Utilization: Room supports both robotic and manual procedures
• Lower Ownership Cost: Standard power and reduced infrastructure complexity

CEO David Fischel has stated that GenesisX orders are expected to outpace Genesis adoption once full launch commences, as the new platform removes structural barriers that previously limited physician interest from converting to installations.

Frequently Asked Questions

How quickly can GenesisX be installed?

GenesisX can be installed in an existing cardiac cath lab over a weekend (2-3 days) without any room construction or modification required.

Can the room be used for non-robotic procedures?

Yes, when GenesisX is parked, the magnetic fields are shielded within the base, allowing the room to function normally for manual catheter procedures without any restrictions.

What is the difference between GenesisX and Genesis?

Genesis requires dedicated room construction with magnetic shielding in the walls, while GenesisX integrates shielding into the system itself. Clinical capabilities are equivalent, but GenesisX dramatically reduces installation time and cost.